David Hirschman

David Hirschman: Attorney with Greenberg Traurig, LLP

Biography

David Hirschman is of counsel in the London office and focuses his practice on corporate and securities matters, with an emphasis on mergers and acquisitions. His experience includes advising on a wide range of corporate and commercial matters for major clients, both in the transactional context and in relation to day-to-day business activities. He is experienced in handling complex cross-border and domestic transactions, investments and reorganizations, advising a range of domestic and international clients from various industries. Having worked in the music industry for a number of years prior to becoming a lawyer, and having spent periods of time working in-house at ITV plc and AstraZeneca plc, he also has substantial business-level experience.

Concentrations

•Mergers and acquisitions
•Corporate finance and investments
•Joint ventures and business reorganisations
•General corporate and commercial advice
•Commercial contracts

Recognition & Leadership

Awards & Accolades

•Listed, The Legal 500 United Kingdom, Corporate/M&A: Lower Mid-Market Deals, 2026

See more ›

Areas of Practice (4)

  • Corporate
  • Mergers & Acquisitions
  • Private Equity
  • Life Sciences & Medical Technology

Education & Credentials

University Attended:
Trinity College of Music, Fellow, 1990
Law School Attended:
BPP Law School, Legal Practice Course, with distinction, 2010; BPP Law School, Graduate Diploma in Law, 2009
Year of First Admission:
2010
Admission:
2010, England and Wales
Reported Cases:
Experience: Representative Matters: Represented Black Dragon Capital in connection with its acquisition of Grass Valley, a leading technology supplier of advanced broadcast and media solutions, with operations in over 20 different jurisdictions worldwide.; Advised AstraZeneca AB on its agreement with Grunenthal to divest the European rights to Nexium for an upfront payment of $700 million with further sales-related and milestone payments of up to $90 million.; Advised AstraZeneca AB on its agreement with Grunenthal to divest the global rights to Vimovo in all markets excluding the US and Japan for an upfront payment of $115 million and further payments up to another $17 million.; Advised Abris Capital Partners in relation to shareholder arrangements relating to its acquisition of Velvet CARE sp. z o.o., one of the largest manufacturers of hygiene products in Poland.; Advised AstraZeneca plc on the sale of its small molecule antibiotics business to Pfizer for US $1.2 billion.; Advised Nomad Foods on its 2.6 billion acquisition of Iglo Foods.; Advised Nomad Foods on its 500 million acquisition of Findus Group's Continental European Business.; Advised Smiths Group plc on its 140 million divestment of the Wallace product line to CooperSurgical.; Advised Gilde Buy Out Partners in the 25 million private equity backed management buyout of the Synbra UK business.; Representation in the $36 million sale of an oil and petroleum marketing and supply group based in Africa to a major global commodities trading and logistics group.; Representation in the dissolution of a joint venture in the defence industry.; Representation in the international expansion of a Bahamas construction operator.; Representation in the winding down of the Forensic Science Service.; Representation of the broker and nomad to AIM listed Fastjet plc in a placing and open offer of shares for 15 million.; Representation of AIM listed Europa Oil and Gas in a cash box placing and open offer of shares for 5 million.; The above representations were handled by Mr. Hirschman prior to his joining Greenberg Traurig, LLP.; Previous Experience: Charles Russell Speechlys LLP, 2010-2015; Director and Trustee, Royal Philharmonic Orchestra Limited, 1990-2010
ISLN:
921665975

Peer Reviews

This lawyer does not have peer reviews.

Client Reviews Write a Review

Location

Contact David Hirschman

Contact Information:

207-900-3632  Fax

www.gtlaw.com/People/David-Hirschman

Required Fields

Required Fields

Clear All Fields

By clicking on the "Submit" button, you agree to the Terms of Use, Supplemental Terms and Privacy Policy. You also consent to be contacted at the phone number you provided, including by autodials, text messages and/or pre-recorded calls, from Martindale and its affiliates and from or on behalf of attorneys you request or contact through this site. Consent is not a condition of purchase.

You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The Internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.